Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 139Neoplasms 118Prostatic Neoplasms 64Lung Neoplasms 48Head and Neck Neoplasms 46Colorectal Neoplasms 38Ovarian Neoplasms 33Uterine Cervical Neoplasms 29Endometrial Neoplasms 23Motor Activity 22Neoplasm Metastasis 20Multiple Myeloma 20Pancreatic Neoplasms 19Brain Neoplasms 19Rectal Neoplasms 18Lymphoma 17Colonic Neoplasms 17Pain 16Gastrointestinal Neoplasms 16Fatigue 16Carcinoma, Non-Small-Cell Lung 16Leukemia 15Depression 15Oropharyngeal Neoplasms 13Melanoma 13Anxiety Disorders 13Urinary Bladder Neoplasms 12Hematologic Neoplasms 12Esophageal Neoplasms 12Stomach Neoplasms 11

Interventions

AZD 6244 11trametinib 4pirfenidone 3mirdametinib 2dabrafenib 2cabozantinib 2Imatinib Mesylate 2tipifarnib 1peginterferon alfa-2b 1nilotinib 1cediranib 1binimetinib 1Vinblastine 1Surveys and Questionnaires 1Sorafenib 1Pharmacokinetics 1Methotrexate 1Liquid Biopsy 1Gadolinium DTPA 1Fluorodeoxyglucose F18 1Everolimus 1Cryotherapy 1Control Groups 1Acceptance and Commitment Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neurofibroma, Plexiform × Surveys and Questionnaires × Clear all
NCT03531814 2024-06-11

Medication Adherence in Children, Adolescents and Adults With Neurofibromatosis Type 1(NF1) on Clinical Treatment Trials

National Institutes of Health Clinical Center (CC)

Phase NA Completed
12 enrolled 18 charts
CNS

Neurofibromatosis 1, Neurofibroma, Plexiform

Data powered by HemOnc (CC BY 4.0) Colophon âš¡